Heimdall Insights

Global Atherosclerosis Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Atherosclerosis Therapeutics Market was valued at $45.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.5% CAGR, to an estimated market size of $58.8 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global atherosclerosis therapeutics market comprises pharmaceutical interventions and biologic therapies specifically indicated for the management of arterial plaque buildup. This includes lipid-lowering agents (statins, PCSK9 inhibitors, and siRNA), antiplatelet drugs, and anti-inflammatory medications used to prevent cardiovascular events like myocardial infarction and stroke. The scope excludes general surgical hardware but includes interventional drug-device combinations and excludes non-specific antihypertensive treatments unless used as part of a primary atherosclerosis regimen.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Atherosclerosis Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Statins
  • PCSK9 Inhibitors & Biologics
  • Antiplatelet Agents
  • Other Therapies